Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Cancer- and cancer treatment-related conditions
Stage/Subtype:  oral complications
Country:  U.S.A.
Trial Type:  Supportive care
Results 1-25 of 27 for your search:
Start Over
Radiation Therapy with or without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
Phase: Phase III
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: RTOG 0920, NCI-2011-00878, CDR0000651536, NCT01311063, NCT00956007
Acupuncture in Treating Dry Mouth Caused by Radiation Therapy in Patients with Head and Neck Cancer
Phase: Phase III
Type: Supportive care
Age: Not specified
Trial IDs: 97115, NCI-2011-02073, CDR0000674208, WF 97115, WFU-97115, MDA-04-01, NCT01141231
Acupuncture in Preventing Radiation-Induced Xerostomia
Phase: Phase III
Type: Supportive care
Age: 18 and over
Trial IDs: 2010-0584, NCI-2011-00306, NCT01266044
Doxepin Hydrochloride or DLA Rinse in Reducing Oral Mucositis Pain in Patients with Head and Neck Cancer undergoing Radiation Therapy
Phase: Phase III
Type: Supportive care
Age: 18 and over
Trial IDs: A221304, NCI-2014-01877, NCT02229539
Clobetasol Propionate in Treating Patients with Oral Chronic Graft-Versus-Host Disease
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Age: 12 to 99
Trial IDs: 12-C-0068, NCI-2013-01531, 120068, P11922, NCT01557517
Ketamine Hydrochloride in Reducing Pain in Patients With Mucositis Undergoing Chemoradiation or Radiation Therapy For Head and Neck Cancer
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: DMS 1022, NCI-2012-01913, D1022, NCT01653327
Personalized Humidification Device in Improving Quality of Life and Reducing Side Effects in Patients With Head and Neck Cancer Undergoing Radiation Therapy
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Age: 18 and over
Trial IDs: 13-10937, NCI-2013-01745, 072084, 13202, NCT01930435
Bovine Lactoferrin Supplement in Improving Taste in Patients With Cancer Receiving Chemotherapy
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Age: 18 and over
Trial IDs: CCCWFU 98513, NCI-2013-01741, NCT01941810
A Dose Escalating Study of SGX942 for Oral Mucositis in Patients With Head and Neck Cancer
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: IDR-OM-01, NCI-2013-02458, NCT02013050
Phase 2, Single Arm, Open Label Study of Folotyn in Combination With Oral Leucovorin to Prevent or Reduce Mucositis in Patients With PTCL
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: SPI-FOL-14-201, NCI-2015-00888, NCT02106650
Topical Sirolimus in Treating Patients with Refractory Oral Chronic Graft-versus-Host Disease
Phase: Phase II
Type: Supportive care
Age: 4 and over
Trial IDs: 14-090, NCI-2014-01564, NCT02123966
Safety and Efficacy of Human Myeloid Progenitor Cells (CLT-008) During Chemotherapy for Acute Myeloid Leukemia
Phase: Phase II
Type: Supportive care
Age: 55 and over
Trial IDs: CLT008-03, NCI-2014-02461, NCT02282215
A Phase 1 Dose Escalation Study of GC4419 in Combination With Chemoradiation for Squamous Cell Cancer of the Head & Neck
Phase: Phase I
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Age: 18 and over
Trial IDs: GT-001, NCI-2013-01796, NCT01921426
Laser Surgery or Electrocautery Surgery in Improving Pain and Quality of Life in Patients With Precancerous or Early Stage Oral Cancer
Phase: No phase specified
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: 11-034, NCI-2011-00924, NCT01355926
Dexamethasone in Reducing Oral Pain and Dry Mouth after Surgery in Patients with Oropharyngeal Cancer
Phase: No phase specified
Type: Supportive care, Treatment
Age: 18 andover
Trial IDs: 8071, NCI-2012-02780, CPC-12095-L, CR00021919, NCT01748942
Genistein in Reducing Treatment-Related Dry Mouth in Patients with Stage III-IV Oropharyngeal Squamous Cell Cancer Undergoing Chemoradiotherapy
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Age: 18 to 95
Trial IDs: RAD2412-13, NCI-2014-01424, IRB00065591, NCI-2014-01402, NCT02075112
Individualized High Dose Methotrexate in Treating Younger Patients With Cancer and Significant Risk for Side Effects
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Age: 1 to 22
Trial IDs: H-33119, NCI-2014-00923, NCT02076997
Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients with Head and Neck Cancer Undergoing Radiation Therapy
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Age: 18 and over
Trial IDs: MC13C2, NCI-2014-00865, Mod13-007632-07, NCT02123511
Pulsed Dye Laser in Treating Patients with Post Radiation Dysphonia
Phase: No phase specified
Type: Supportive care
Age: Not specified
Trial IDs: CCCWFU 98214, NCI-2014-01458, NCT02198131
Start Over